Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas

被引:9
|
作者
Permuth, Jennifer B. [1 ,2 ]
Vyas, Shraddha [2 ]
Li, Jiannong [3 ]
Chen, Dung-Tsa [3 ]
Jeong, Daniel [2 ,4 ]
Choi, Jung W. [4 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Diagnost Imaging & Intervent Radiol, Tampa, FL 33612 USA
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
radiomics; cancer disparities; pancreatic cancer; quantitative imaging; blacks; CT TEXTURE ANALYSIS; TUMOR HETEROGENEITY; RACIAL DISPARITIES; AFRICAN-AMERICANS; TEST-RETEST; CANCER; SURVIVAL; REPRODUCIBILITY; CONSEQUENCES; RACE;
D O I
10.3389/fonc.2021.712950
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Significant racial disparities in pancreatic cancer incidence and mortality rates exist, with the highest rates in African Americans compared to Non-Hispanic Whites and Hispanic/Latinx populations. Computer-derived quantitative imaging or "radiomic " features may serve as non-invasive surrogates for underlying biological factors and heterogeneity that characterize pancreatic tumors from African Americans, yet studies are lacking in this area. The objective of this pilot study was to determine if the radiomic tumor profile extracted from pretreatment computed tomography (CT) images differs between African Americans, Non-Hispanic Whites, and Hispanic/Latinx with pancreatic cancer. Methods: We evaluated a retrospective cohort of 71 pancreatic cancer cases (23 African American, 33 Non-Hispanic White, and 15 Hispanic/Latinx) who underwent pretreatment CT imaging at Moffitt Cancer Center and Research Institute. Whole lesion semi-automated segmentation was performed on each slice of the lesion on all pretreatment venous phase CT exams using Healthmyne Software (Healthmyne, Madison, WI, USA) to generate a volume of interest. To reduce feature dimensionality, 135 highly relevant non-texture and texture features were extracted from each segmented lesion and analyzed for each volume of interest. Results: Thirty features were identified and significantly associated with race/ethnicity based on Kruskal-Wallis test. Ten of the radiomic features were highly associated with race/ethnicity independent of tumor grade, including sphericity, volumetric mean Hounsfield units (HU), minimum HU, coefficient of variation HU, four gray level texture features, and two wavelet texture features. A radiomic signature summarized by the first principal component partially differentiated African American from non-African American tumors (area underneath the curve = 0.80). Poorer survival among African Americans compared to Non-African Americans was observed for tumors with lower volumetric mean CT [HR: 3.90 (95% CI:1.19-12.78), p=0.024], lower GLCM Avg Column Mean [HR:4.75 (95% CI: 1.44,15.37), p=0.010], and higher GLCM Cluster Tendency [HR:3.36 (95% CI: 1.06-10.68), p=0.040], and associations persisted in volumetric mean CT and GLCM Avg Column after adjustment for key clinicopathologic factors. Conclusions: This pilot study identified several textural radiomics features associated with poor overall survival among African Americans with PDAC, independent of other prognostic factors such as grade. Our findings suggest that CT radiomic features may serve as surrogates for underlying biological factors and add value in predicting clinical outcomes when integrated with other parameters in ongoing and future studies of cancer health disparities.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas
    Zhang, K.
    Yao, H.
    Yang, Z.
    Li, D.
    Yang, L.
    Zou, Q.
    Yuan, Y.
    Miao, X.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (04) : 352 - 359
  • [32] Macroscopic features predict outcome in patients with pancreatic ductal adenocarcinoma
    Hori, Shutaro
    Shimada, Kazuaki
    Ino, Yoshinori
    Oguro, Seiji
    Esaki, Minoru
    Nara, Satoshi
    Kishi, Yoji
    Kosuge, Tomoo
    Hattori, Yukinori
    Sukeda, Aoi
    Kitagawa, Yuko
    Kanai, Yae
    Hiraoka, Nobuyoshi
    VIRCHOWS ARCHIV, 2016, 469 (06) : 621 - 634
  • [33] Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma
    Komura, Takuya
    Takabatake, Hisashi
    Harada, Kenichi
    Yamato, Masatoshi
    Miyazawa, Masaki
    Yoshida, Keiko
    Honda, Masao
    Wada, Takashi
    Kitagawa, Hirohisa
    Ohta, Tetsuo
    Kaneko, Shuichi
    Sakai, Yoshio
    CANCER SCIENCE, 2017, 108 (11): : 2122 - 2129
  • [34] Relationship between pancreatic intraepithelial neoplasias, pancreatic ductal adenocarcinomas, and single nucleotide polymorphisms in autopsied elderly patients
    Matsuda, Yoko
    Tanaka, Masashi
    Sawabe, Motoji
    Mori, Seijiro
    Muramatsu, Masaaki
    Mieno, Makiko Naka
    Furukawa, Toru
    Arai, Tomio
    GENES CHROMOSOMES & CANCER, 2018, 57 (01) : 12 - 18
  • [35] A and B Blood Group Antigens in Human Pancreatic Ductal Adenocarcinomas
    Handra-Luca, Adriana
    ONCOLOGY, 2013, 84 (03) : 141 - 149
  • [36] Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy
    Zhuang, Hongkai
    Zhou, Zixuan
    Ma, Zuyi
    Huang, Shanzhou
    Gong, Yuanfeng
    Li, Zhenchong
    Liu, Chunsheng
    Wang, Shujie
    Chen, Bo
    Zhang, Chuanzhao
    Hou, Baohua
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [37] The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids
    Low, Ronnie Ren Jie
    Lim, Wei Wen
    Nguyen, Paul M.
    Lee, Belinda
    Christie, Michael
    Burgess, Antony W.
    Gibbs, Peter
    Grimmond, Sean M.
    Hollande, Frederic
    Putoczki, Tracy L.
    CANCERS, 2021, 13 (19)
  • [38] Mutations in KRAS: are they a valid biomarker for pancreatic ductal adenocarcinomas diagnosis?
    Narayanan, Vilvapathy
    Konstantinov, Sergey R.
    Peppelenbosch, Maikel P.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S72 - S77
  • [39] Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas
    Hinton, Jesse
    Callan, Richard
    Bodine, Charlie
    Glasgow, Wayne
    Brower, Steve
    Jiang, Shi-Wen
    Li, Jinping
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2013, 13 (05) : 431 - 443
  • [40] Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
    Handra-Luca, A.
    Hong, S-M
    Walter, K.
    Wolfgang, C.
    Hruban, R.
    Goggins, M.
    BRITISH JOURNAL OF CANCER, 2011, 104 (08) : 1296 - 1302